Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled, Randomized, Double-blind, Multi-center, Multinational Phase IIb Study to Investigate the Efficacy and Tolerability of BAY58-2667 Given Intravenously in Patients With Decompensated Chronic Congestive Heart Failure

NCT00559650 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00559650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled, Randomized, Double-blind, Multi-center, Multinational Phase IIb Study to Investigate the Efficacy and Tolerability of BAY58-2667 Given Intravenously in Patients With Decompensated Chronic Congestive Heart Failure
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2007
Completion date
March 31, 2009
Enrollment
150 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure